Parenteral formulations comprising carbamazepine or its derivatives
US6316417A · kind A · utility
0Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 2, 2000 |
| Grant date | Nov 13, 2001 |
| Priority date | — |
| Expiry date | May 2, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is concerned with a parenteral formulation comprising a 5H-dibenz(b,f)azepine-5-carboxamide and an aqueous-based solvent. The parenteral formulation is useful in the treatment of seizures resulting from, e.g. epileptic attack.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.